Introduction
Photodynamic therapy (PDT) is now recognized as an alternative cancer therapy that offers a lower degree of invasiveness and milder adverse side effects [1] [2] [3] [4] [5] [6] [7] [8] . PDT drugs currently approved for use and those undergoing clinical trials are organic molecules that rely on the sensitized formation of 1 O 2 [1] [2] [3] [4] [5] [6] [7] [8] . In contrast to these systems, transition metal complexes with photolabile ligands offer different modes of action that may prove superior to the present PDT drugs under certain conditions, such as hypoxia [3, 9, 10] . The photochemistry of Ru(II) complexes with photolabile monodentate ligands is independent of the presence of oxygen, which represents an alternative to traditional PDT agents.
The compounds cis-[Ru(bpy) 2 (NH 3 ) 2 ] 2+ (bpy = 2, 2 -bipyridine) [11] , cis-[Ru(bpy) 2 (5-CNU) 2 ] 2+ (5-CNU = 5-cyanouracil) [12] and cis- [Ru(bpy) 2 (NC-peptide) 2 ] 2+ (NC-peptide = nitrile-terminated cysteine protease inhibitor) [13, 14] have been shown to undergo ligand exchange with solvent water molecules upon irradiation. The initial photolysis in water produces the corresponding complex, [Ru(bpy) 2 2+ , with quantum yields, Φ, of 0.018 (λ irr = 400 nm) and 0.16 (λ irr ≥ 400 nm), respectively, followed by the formation of cis- [Ru(bpy) 2 (H 2 O) 2 ] 2+ with continued irradiation [11, 12] . The cation cis- [Ru(bpy) 2 2 ] 2+ , known to covalently bind to nuclear DNA and disrupt cellular processes, including transcription and translation [15] [16] [17] [18] [19] . Similarly, the formation of cis- [ 6 ] 2+ is observed in water upon irradiation with visible light (Φ = 0.09, λ irr = 509 nm); the product binds covalently to ds-DNA, and a 34-fold increase in toxicity is observed with photolysis [20] . Therefore, these photoreactive ruthenium and dirhodium complexes may exhibit therapeutic action that resembles that of cisplatin, but the advantage is that they only become active upon irradiation. Such activation can be used to increase the specificity towards tumours, because only the affected areas are irradiated selectively, thus decreasing the adverse side effects observed with thermally activated drugs, such as cisplatin [15] [16] [17] [18] [19] . It should be noted that related complexes have been shown to reach the cellular nucleus and, upon irradiation with visible light, to cross-link the nuclear proteins p53 and PCNA, as well as to form protein-DNA adducts, and to inhibit DNA replication [21] ; moreover, other ruthenium complexes are undergoing clinical trials [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] .
The maximum tissue penetration of light takes place in the range of 600-850 nm, typically termed the PDT window. It is therefore desirable for a PDT agent to absorb light and to be activated in this spectral region. In the case of [Ru(bpy) 2 (L) 2 ] 2+ (L = NH 3 , pyridine, CH 3 CN) complexes, the lowest energy transition is Ru → bpy metal-to-ligand charge transfer (MLCT) in character. It has been shown in related complexes that a red-shift in the MLCT absorption can be achieved by introducing cyclometallating ligands, such as phpy − (deprotonated 2-phenylpyridine) [33] . In these systems, the covalent nature of the ruthenium-carbon bond to the phpy-ligand results in an increase in energy of the highest-occupied molecular orbital (HOMO) of the complex, thus reducing the energy required to move an electron from the HOMO to low-lying phen or bpy π * orbitals. This red-shift in the MLCT absorption of cyclometallated ruthenium complexes makes them potentially useful as PDT agents.
Cis- [Ru(phpy) (phen)(CH 3 CN) 2 ](PF 6 ) (1; phen = 1,10-phenanthroline) has been shown to inhibit the growth of tumours in mice [34] . In later work, its cytotoxicity was noted to vary with exposure to light. However, photophysical studies were not undertaken, and the differences in reactivity were left unexplained [35] . Complex 1 has also been shown to enhance the efficiency of the fungal enzyme laccase when incorporated in the protein as the catalytic centre [36] . This study explores the electronic structure and photo-induced ligand dissociation of cis- [Ru(phpy) (2) . Owing to the large intracellular concentration of glutathione (GSH), experiments aimed at elucidating the reactivity of GSH with 1 and 2 in the dark and under irradiation were also conducted to explore its possible role in the production of reactive species. 
Experimental (a) Materials
L-GSH in the reduced (99%; Sigma-Aldrich) and oxidized (98%; Acros Organics) forms were used as purchased from the supplier. For the cell viability studies, NIH:OVCAR-5 cells (OVCAR-5) were obtained from Thomas Hamilton, Fox Chase Cancer Institute (Philadelphia, PA) and maintained in RPMI-1640 (Mediatech Inc., Herndon, VA) supplemented with 10 per cent heat-inactivated foetal bovine serum (Gibco Life Technologies, Grand Island, NR), 100 U ml −1 penicillin and 100 mg ml −1 streptomycin. MTT (thiazolyl blue tetrazolium bromide) was purchased from Sigma and used as received. Sodium phosphate, gel loading buffer (0.05% (w/v) bromophenol blue, 40% (w/v) sucrose, 0.1 M EDTA (pH = 8.0), 0.5% (w/v) sodium lauryl sulfate), Tris base, Tris/HCl and ethidium bromide were purchased from Sigma and used as received.
Cis- [Ru(phpy) (1) was prepared through a modified method [37, 38] . Under argon and shielded from light, [Ru(phpy)(MeCN) 4 ](PF 6 ) (612 mg, 1.08 mmol) and 1,10-phenanthroline (195 mg, 1.08 mmol) in dry MeCN (50 ml) were stirred at room temperature for 15 h. The solvent was evaporated, and the product was purified by chromatography on Al 2 O 3 , eluting with CH 2 Cl 2 . The red band was collected and crystallized from ether to provide 1 as red-brownish crystals (482 mg, 67%): 1 
(b) Instrumentation and methods
Electrospray ionization-mass spectrometry (ESI-MS) measurements were undertaken on a Bruker MicrOTOF spectrometer with ESI equipped with an Agilent 1200LC and analysed using the DALTONICS DATA ANALYSIS software v. 3.4 (Bruker). 1 H NMR spectra were recorded on a 400 MHz Bruker instrument. Sample photolysis was performed by positioning a borosilicate NMR tube at the focal point of a 150 W Xe arc lamp. The irradiation wavelength was controlled by placing a 455 nm long-pass glass filter and a 10 cm water cell in front of the light source. The Xe arc lamp was powered by an LPS-220 power supply equipped with an LPS-221 igniter in a Photon Technology International upright housing. Electronic absorption spectra were recorded using a Hewlett Packard diode array spectrometer (HP 8453) with HP 8453 WIN SYSTEM software. Ethidium-bromide-stained gels were imaged on a Gel Doc 2000 (BioRad) transilluminator with QUANTITY ONE software.
The ESI-MS spectrometry and 1 H NMR spectroscopy experiments were performed in a DMSOd 6 : D 2 O mixture (33 : 67 (v/v)). For the cell viability studies, the 690 ± 5 nm output of a solid-state diode laser (BWF 690-1; B&W TEK, Newark, DE) was focused to an approximately 3.5 cm diameter spot with an irradiance of 50 mW cm −2 . The OVCAR-5 cells were plated in 35 mm dishes, incubated with complex 1 for 15 h, and subsequently illuminated for 100 s with 5 J cm −2 using the 690 ± 5 nm output from a solid-state diode laser (BWF 690-1; B&W TEK) focused to an approximately 3.5 cm diameter spot with an irradiance of 50 mW cm −2 . The complexes were solubilized in biological grade DMSO prior to dosing. Care was taken throughout the toxicity experiments to not exceed 5 per cent DMSO (by volume), which is the determined threshold for OVCAR-5 cells in which 95 per cent cell killing is observed compared with no treatment (media only) controls. The MTT assay was performed 24 h after irradiation using typical methods; the cells were incubated with 0.5 mg ml −1 MTT for 1 h to measure their reduction by mitochondrial dehydrogenases as recommended by the manufacturer (Sigma). 
Results and discussion (a) Electronic absorption
Complexes 1 and 2 exhibit absorption in the ultraviolet and visible regions consistent with those reported for related cyclometallated complexes [33] . Intense ligand-centred ππ * transitions were observed in CH 2 . It should also be noted that the lowest energy MLCT peak in both complexes has a tail that extends well beyond 600 nm, a desirable feature of PDT agents.
(b) Photochemistry and phototoxicity
Irradiation of 1 with visible light in CH 2 Cl 2 in the presence of excess tetrabutylammonium chloride (TBACl) results in a photochemical transformation that can be followed by electronic absorption and 1 H NMR spectroscopies. The changes to the absorption spectrum of 130 µM 1 in the presence of 2 mM TBACl in CH 2 Cl 2 are shown in figure 1 as a function of time (λ irr ≥ 420 nm). The spectra show a decrease in the absorption features of the reactant accompanied by an increase in absorption of a broad peak with maximum at 565 nm within 2 min of irradiation. The presence of two isosbestic points at 346 nm and 500 nm is consistent with the formation of a single species from the reactant at irradiation times up to 3 min (figure 1). The inset of figure 1 shows that there are no changes when the sample was kept in the dark over a period of 24 h at room temperature. [42] . Continued photolysis of the sample results in an increase in the 1 H NMR peak corresponding to free CH 3 CN, with its integration reaching two equivalents after 30 min of irradiation, consistent with the formation of the bis-substituted complex [Ru(phpy)(phen)Cl 2 ] − . The viability of OVCAR-5 cells in the presence of 1 was explored under irradiation and in the dark. OVCAR-5 is a human advanced ovarian epithelial cancer cell line that exhibits some resistance to cisplatin [43] . For the experiments conducted in the dark, care was taken to control light exposure throughout the assay. The LC dark 50 value (the concentration of complex required to reduce the viability of 50% of the cells) was measured to be 1.0 µM after 39 h exposure to 1 in the dark, where the cells were exposed to 1 for 15 h, the medium was replaced with fresh medium, then allowed to grow for another 24 h. This procedure was chosen to match that of the irradiated samples, which were exposed to the complex for 15 h, the medium was then replaced with drug-free medium prior to irradiation for 100 s, and the cells were then allowed to grow for 24 h prior to MTT assay. Irradiation of the sample with 690 nm resulted in an LC value measured for 1 compares well with those reported for the 48 h exposure of other cancer cell lines to the complex, including human glioblastoma A-172 (1.9 ± 0.2 µM), adenocarcinoma HCT-116 (3 ± 2 µM) and lymphoma RDM-4 (10 ± 5 µM) [35] .
(c) Photo-induced binding to DNA and the role of GSH
In order to gain further insights into the effect of photochemical ligand exchange on the increased cell toxicity with irradiation, the photo-induced binding of 1 to DNA was probed. It was previously shown that the covalent binding of cisplatin to ds-DNA results in reduced electrophoretic mobility in agarose gels [20] . It is evident from the data in figure 2a that addition of up to threefold excess of 1 (lanes 3-6) to 100 µM DNA does not change the DNA mobility, when compared with lanes 2 and 7 with no ruthenium complex present. The results in figure 3 show that GSH facilitates ligand exchange of 1 and 2 with solvent DMSO-d 6 molecules. Intracellularly, in the absence of DMSO, such ligand exchange may result in the covalent binding of the complex to DNA and other biomolecules. Because the stock solutions for the cellular viability studies were prepared in DMSO, it is possible that a DMSO-coordinated product is playing a role in the toxicity observed upon irradiation. The mass spectra in figure 4 show the result of irradiation of a solution that was incubated with GSH in the dark for 20 h. Figure 4c shows a decrease in the relative intensity of the parent ion peak, A, after irradiation compared with GSH alone ( figure 4a,b) , which represents a relative increase of the DMSO-bound products C, D, E and F. Product F can be associated with the addition of an oxygen atom or hydroxide to product D. Although the identity of the product peaks appears to be the same in the mass spectra collected before and after photolysis, Ru(II)-DMSO complexes are well known to undergo isomerization upon irradiation from the S-bound to O-bound complex [44] [45] [46] . Indeed, the absorption spectrum of the photolysis product of a solution containing 78 µM of 1 and 10 eq of GSH in DMSO : H 2 O (33 : 67 (v/v)) is red-shifted relative to that of the reactant, consistent with S → O isomerization [44] [45] [46] . The O-bound DMSO in these complexes is more susceptible to ligand substitution than the S-bound ligand, such that the former may undergo ligand exchange and bind to biomolecules.
Because it is known that GSH undergoes some oxidation in the presence of DMSO to generate the corresponding disulfide dimer, GSSG [47] , the effect of GSSG on 1 was investigated both in the dark and upon irradiation. A comparison of figure 4d, e reveals that incubation of 670 µM of 1 with 5 eq of GSSG in DMSO-d 6 
Conclusions
This study demonstrated that cyclometallated complexes of ruthenium(II) provide a means to shift the absorption to lower energies. Indeed, complexes 1 and 2 undergo photo-induced ligand exchange and are active in the PDT window. Enhanced toxicity is observed for 1 upon irradiation with 690 nm light, and the complex covalently binds to DNA upon irradiation. This work shows that intracellular GSH may play a role in enhancing ligand substitution both in the dark and upon irradiation, such that the enhanced phototoxicity may result from a combination of the photo-induced ligand exchange and the reactivity with GSH. Additional studies to gain a better understanding of the role of GSH in the observed biological activity are currently underway.
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